OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(3)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Repository
pride
(1)
Disease
Lymphoma
(1)
Technology Type
Affinity purification coupled with mass spectrometry proteomics
(1)
Gel-based experiment
(1)
Mass Spectrometry
(1)
Publication Date
2022
(1)
Release Date
2025
(1)
2021
(1)
2015
(1)
Lab affiliation
1) CNRS - ITAV USR3505, 31106 Toulouse, France 2) Nova Medical School, CEDOC- Chronic Diseases, 1150-082, Lisboa, Portugal
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Proteaphagy contributes to bortezomib resistance in mantle cell lymphoma
TUBE and GST enrichment followed by 1D-gel-LC-MS analysis on cell exract from bortezomib (BTZ)-resistant or sensitive mantle cell lymphoma cells.
ORGANISM(S):
Homo sapiens (Human)
2022-02-28
|
PXD011867
|
Pride
Ubiquitin proteasome system
Lymphoma
Proteaphagy
Bortezomib resistance
Tubes
Cite
Rationale and study design for an individualized perioperative open lung ventilatory strategy (iPROVE): study protocol for a randomized controlled trial.
Not available
S-EPMC4425893
|
biostudies-literature
Cite
Association of intraoperative end-tidal CO<sub>2</sub> levels with postoperative outcomes: a patient-level analysis of two randomised clinical trials.
Not available
S-EPMC12799414
|
biostudies-literature
Cite
Mapping the human genetic architecture of COVID-19.
Not available
S-EPMC8674144
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
